CASI PHARMACEUTICALS, INC. (CASIF) Deferred Tax Assets, Other

CASI PHARMACEUTICALS, INC. Deferred Tax Assets, Other

CASI PHARMACEUTICALS, INC. (CASIF) had Deferred Tax Assets, Other of $496.00 thousand as of 2025-12-31, per its 20-F filed 2026-05-15.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOther · last filed 2026-05-15

• 2025-12-31: Deferred Tax Assets, Other $496.00K.
• 2024-12-31: Deferred Tax Assets, Other $233.00K; Deferred Tax Assets, Other as first filed $246.00K.
• 2023-12-31: Deferred Tax Assets, Other $254.00K.
• 2022-12-31: Deferred Tax Assets, Other $368.00K.